Immunosuppression-Associated Lymphoproliferative Disorders in Rheumatic Patients

References

• Nalesnik M.A., Makowka L., Starzl T.E. The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr. Probl. Surg. 1988; 25(6)367–472
   PubMed Web of Science ®Google Scholar
• Nalesnik M.A., Jaffe R., Starzl T.E., et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am. J. Pathol 1988; 133(1)173–92
   PubMed Web of Science ®Google Scholar
• Knowles D.M., Chamulak G.A., Subar M., et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 1988; 108: 744–53
   PubMed Web of Science ®Google Scholar
• Biemer J.J. Malignant Lymphomas Associated with Immunodeficiency States. Annals Clin. Lab. Sci. 1990; 120(3)175–191
   Google Scholar
• Starzl T.E., Nalesnik M.A., Porter K.A., et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1986; 1(8377)583–7
   PubMed Web of Science ®Google Scholar
• Staal S.P., Ambinder R., Beschomer W.E., et al. A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease. Am. J. Clin. Pathol. 1989; 91(1)1–5
   PubMed Web of Science ®Google Scholar
• Cleary M.L., Nalesnik M.A., Shearer W.T., Sklar J. Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 1988; 72(1)349–52
   PubMed Web of Science ®Google Scholar
• Young L., Alfieri C., Hennessy K., et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 1989; 321(16)1080–5
   PubMed Web of Science ®Google Scholar
• Purtillo D.T., Strobach R.S., Okano M., Davis J.R. Epstein-Barr virus-associated lymphoproliferative disorders. Lab. Invest. 1992; 67: 5–23
   PubMed Web of Science ®Google Scholar
• Filipovich A.H., Mathus A., Kamat D., Shapiro R.S. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res. 1999; 52(suppl)5465s–5467s
   Google Scholar
• Castor C.W., Bull F.E. Review of United States data on neoplasms in rheumatoid arthritis. Am. J. Med. 1985; 78(suppl 1A)33–38
   PubMed Web of Science ®Google Scholar
• Hakulinen T., Isomaki H., Knekt P. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am. J. Med. 1985; 78(suppl 1A)29–32
   PubMed Web of Science ®Google Scholar
• Kinlen L.J. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am. J. Med. 1985; 78(suppl 1A)44–55
   PubMed Web of Science ®Google Scholar
• Prior P. Cancer and rheumatoid arthritis: epidemiologic considerations. Am. J. Med. 1985; 78(suppl 1A)15–21
   PubMed Web of Science ®Google Scholar
• Symmons D.P. Neoplasms of the immune system in rheumatoid arthritis. Am. J. Med. 1985; 78(suppl 1A)22–28
   PubMed Web of Science ®Google Scholar
• Kinlen L.J. Malignancy in autoimmune diseases. J. Autoimmun. 1992; 5(suppl A)363–371
   PubMed Web of Science ®Google Scholar
• Fox R.I., Kang H. Pathogenesis of Sjogren's syndrome. Rheum. Dis. North. Am. 1992; 18: 517–538
   PubMed Web of Science ®Google Scholar
• Ellman M.H., Hurwitz H., Thomas C., Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J. Rheumatol. 1991; 18: 1741–3
   PubMed Web of Science ®Google Scholar
• Kamel O.W., van de Rijn M., Weiss L.M., et al. Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. New. Engl. J. Med. 1993; 328(18)1317–1321
   PubMed Web of Science ®Google Scholar
• Shiroky J.B., Frost A., Skelton J.D., et al. Complications of immunosuppression associated with weekly low dose methotrexate. J. Rheumatol 1991; 18(8)1172–5
   PubMed Web of Science ®Google Scholar
• Banks P.M., Witrak G.A., Conn D.L. Lymphoid neoplasia following connective tissue disease. Mayo Clin. Proc 1979; 54: 104–108
   PubMed Web of Science ®Google Scholar
• Freimark B., Fantozzi R., Bone R., et al. Detection of clon-ally expanded salivary gland lymphcyteds in Sjogren's syndrome. Arthritis and Rheumatism 1989; 32: 859–869
   PubMed Web of Science ®Google Scholar
• Tziofas A.G., Katsikis P.D., Youinou P.Y., Moutsopoulow H.M. Sjogren's syndrome: an oligo-monoclonal B cell process. Clin, and Exp. Rheum. 1990; 8(suppl)17–21
   Google Scholar
• McCurley T.L., Collins R.D., Ball E., Collins R.D. Nodal and extranodal lymphproliferative disorders in Shogren's syndrome: A clinical and immunopathologic study. Hum. Pathol. 1990; 12: 482–492
   Web of Science ®Google Scholar
• Weiss L.M. Monocytoid B-cell lymphoma. Hum. Pathol. 1991; 22: 407–408
   PubMed Web of Science ®Google Scholar
• Ortiz-Hidalgo C., Wright D.H. The morphological spectrum of monocytoid B-cell lymphoma and its relationship to lymphomas of mucosa-associated lymphoid tissue. Histopathol 1992; 21: 555–561
   PubMed Web of Science ®Google Scholar
• Shin S.S., Sheibani K., Fishleder A., et al. Monocytoid B-cell lymphoma in patients with Sjogren's syndrome. A clinico-pathologic study of 13 patients. Hum. Pathol 1991; 22: 422–430
   PubMed Web of Science ®Google Scholar
• Ngan B., Warnke R.A., Wilson M., et al. Monocytoid B-cell lymphoma. A study of 36 cases. Hum. Pathol 1991; 22: 409–421
   PubMed Web of Science ®Google Scholar
• Kamel O.W., van de Rijn M., LeBrun D.P., et al. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum. Pathol 1994; 25, in press
   Web of Science ®Google Scholar
• Zijlmans J. M. J. M., van Rijthoven A. W. A. M., Kluin P.M., et al. Epstein-Barr virus-associated lymphoma in a patient with rheumatoid arthritis treated with cyclosporine. New. Engl J. Med. 1992; 326(20)1363
   PubMed Web of Science ®Google Scholar
• Kingsmore S.F., Hall B.D., Allen N.B., et al. Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review. J. Rheumatol 1992; 19(9)1462–1465
   PubMed Web of Science ®Google Scholar
• Shiroky J.B., Newkirk M.M. Reversible lymphomas (letter to the Editor). N. Engl. J. Med 1993; 329: 1657–1658
   PubMed Web of Science ®Google Scholar
• Kamel O.W., van de Rijn M., Warnke R.A., Dorfman R.F. Reversible lymphomas (letter to the Editor). N. Engl. J. Med. 1993; 329: 1658
   Web of Science ®Google Scholar
• Tosato G., Steinberg A.D., Yarchoan R., et al. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J. Clin. Invest. 1984; 73(6)1789–95
   PubMed Web of Science ®Google Scholar
• Depper J., Bluestein H., Zvailer N. Impaired regulation of EB virus induced lymphocyte proliferation in RA is due to a T cell defect. J. Immunol 1989; 127: 1899–902
   Google Scholar